Eight Roads

Eight Roads is a global venture capital firm, established in 1969, that invests in technology and healthcare companies across Asia, Europe, Israel, and the United States. It manages over $11 billion in assets through various funds, including Eight Roads Ventures China, Europe, India, and Japan. The firm focuses on early venture, growth capital, and growth stage investments, typically committing between $1.29 million to $30 million per company. Eight Roads seeks minority and majority stakes, often taking a board seat, and has invested in over 500 companies such as Alibaba, Chewy, and Toast. It operates as the proprietary investment arm of Fidelity International Limited.

Umang Agarwal

Principal

Sanjay Aggarwal

Venture Partner

Hiroki Ashida

Vice President

Daniel Auerbach

Senior Managing Partner and Head of Global Ventures

Vytautas Balsys

Partner

Helena Barman

Investor

Virginia Bassano

Vice President

Shirish Belapure

Venture Partner

Daniel Benjamin

Associate

Betty Cai

Partner

Ted Chua

Senior Partner

Kevin Du

Senior Associate

Raj Dugar

Managing Partner, India

Martin Ericsson

Vice President

Tamina Fogelberg

Associate

Siddhant Gandhi

Associate

Elaine Gao

Senior Associate

Antonin Gury-Coupier

Vice President

Davor Hebel

Managing Partner and Head of Europe

April Hu

Vice President

Tao Huang

Principal

Tammy Huang

Senior Associate

Tao Huang

Principal

Allen Huo

Vice President

Abhishek Jain

Vice President

Zang Jialun

Partner

Junichi Murata

Partner

Deepak Kanvinde

Venture Partner

Michiko Kohyama

Vice President

Shinichiro Komoto

Partner

Kavish Kothari

Principal

Chintan Kothari

Partner

Thomas Lin

Vice President

Xin Liu

Partner

Allen Liu

Senior Associate

Maneesh Menon

Principal

Sophie Meralli

Vice President

Chersy Miao

Principal

David Milstein

Managing Partner and Head of Japan

Jens Neisius

Vice President

Dan O'Toole

Vice President

Yosuke Ouchi

Principal

Delphine Qiu

Principal

Eyal Rabinovich

Principal

Laura Salesse

Senior Associate

Fuga Sawada

Senior Associate

Shawn Shen

Partner

Sagar Sheth

Vice President

Lei Shi Ph.D

Partner

Arjun Singh

Senior Associate

Michael Stephanblome

Venture Partner

Liena Suzuki MD

Principal

Aditya Systla

Partner

Jarlon Tsang

Managing Partner and Head of China

Ashish Venkataramani

Partner

Ashish Venkataramani

Partner

Bo Wang

Senior Associate

He Wang

Vice President

Nancy Xu

Vice President

Cody Yin Ph.D

Partner

Zhang Yixiao

Executive Director

Yuan Yuan

Principal

Alston Zecha

Partner

Gordon Zhang

Partner

Haoming Zhang

Vice President

Feng Zhao Ph.D

Partner

Weimin Liu Ph.D

Partner

582 past transactions

UGOKU

Series B in 2025
UGOKU is a provider of management of personal coaching service.

Salowin

Series D in 2025
Salowin Inc., established in 2019 and headquartered in Tokyo, Japan, operates a unique business model within the beauty industry. The company provides a share salon concept for beauticians, offering private rooms equipped with well-maintained facilities. Salowin supports its tenants through services such as prepayment systems for sales and comprehensive support, enabling beauticians to focus on their craft while benefiting from shared resources and increased income potential.

Swan

Series B in 2025
Swan is a Paris-based fintech company founded in 2019 that specializes in embedded finance through its Banking-as-a-Service platform. It enables businesses to create and manage bank accounts, issue cards, and generate IBANs seamlessly using straightforward APIs. Serving more than 60 clients across ten European countries, Swan handles over 200 million euros in transactions monthly. The company is staffed by over 100 employees, led by experts in the fintech sector. As a licensed financial institution regulated by the ACPR, Swan operates as a principal member of Mastercard, positioning itself as a key player in the European financial technology landscape.

Eleos Health

Series C in 2025
Eleos Health is a technology company that specializes in artificial intelligence-driven solutions for the behavioral health sector. It has developed a voice technology platform designed to enhance clinicians' decision-making by providing real-time insights during mental health sessions. This AI-powered system operates in the background, analyzing voice interactions and other data parameters to generate valuable information about patients. By leveraging this technology, Eleos Health aims to facilitate personalized care, ensuring that mental health professionals can deliver timely and cost-effective support tailored to individual needs.

Beads

Series A in 2025
Beads is a dedicated operator of hospice housing facilities, specializing in providing end-of-life care for patients with terminal cancer or intractable neurological diseases. The company offers a residential setting that combines nursing care and palliative support, aiming to create a comfortable and dignified environment for patients to spend their final days.

Tenpoint Therapeutics

Venture Round in 2024
Tenpoint Therapeutics is a biotechnology company dedicated to developing engineered cell-based therapies aimed at restoring vision for individuals affected by degenerative ocular diseases. The company leverages an innovative platform that includes in vivo reprogramming techniques, allowing for targeted delivery of therapeutic systems directly to the eye. This approach eliminates the need for systemic administration, which can improve treatment efficacy and patient outcomes. By focusing on vision restoration, Tenpoint Therapeutics strives to significantly enhance the quality of life for patients suffering from various eye conditions.

Laurus Bio

Venture Round in 2024
Laurus Bio specializes in precision fermentation, providing expertise as a service for customers involved in microbial fermentation-based manufacturing and product development. The company focuses on the development of non-animal origin recombinant proteins, including media components, growth factors, and supplements for cell culture. Laurus Bio's solutions cater to various applications such as cultured meat production, biologics, insulin manufacturing, vaccine development, and regenerative medicine. By offering innovative enzymatic proteins and related products, Laurus Bio aims to enhance safety, consistency, and traceability in the pharmaceutical, meat, and bio-manufacturing industries, enabling clients to create more sustainable and environmentally friendly products.

Lighthouse

Series C in 2024
Lighthouse is a commercial platform tailored for the travel and hospitality industry, specializing in hotel management solutions. The company offers a cloud-based platform that visualizes and leverages data to enhance business success. By providing actionable market insights and business intelligence tools, Lighthouse enables hoteliers and hotel management companies to make informed revenue and distribution decisions. Its services include real-time data analytics, which empower users to maximize property occupancy rates and increase revenue and profit. Formerly known as OTA Insight, Lighthouse aims to transform complex market dynamics into manageable strategies that foster growth in the hospitality sector.

Bhanzu

Series B in 2024
Bhanzu is an innovative math-learning platform focused on fostering interest in mathematics and STEM careers among students of all ages. Its meticulously designed curriculum provides a customized learning experience tailored to individual needs, helping learners enhance their cognitive abilities and develop a strong foundational understanding of math. The platform features a variety of educational resources, including videos aimed at alleviating math anxiety for young learners in grades 1 to 3. By emphasizing experiential learning, Bhanzu enables students to improve their mathematical skills and apply concepts effectively in real-world scenarios.

Dingzhi Dental

Series A in 2024
Dingzhi Dental is a comprehensive dental service provider, offering a wide array of oral health services including dental implants, orthodontics, aesthetic restoration, periodontal treatment, pediatric dentistry, and general dentistry. The company specializes in dental medical chain management, institutional investment, medical education, and supply chain services, as well as dental institution franchising and discipline co-construction.

AvenCell

Series B in 2024
Based on our deep science and focused on patients in need.

Everstage

Series B in 2024
Everstage is a no-code commissions automation platform founded in 2020 and based in Wilmington, Delaware. The company specializes in providing tools that streamline and enhance the management of sales commissions for customer-facing teams. Its platform offers real-time visibility and insights into performance, allowing businesses to create customized incentive structures while automating repetitive manual tasks. By delivering a transparent and gamified experience, Everstage helps organizations motivate their teams and improve overall performance.

Spry

Series B in 2024
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.

Fat Fee

Series A in 2024
Fat Fee is a health food supplier, mainly engaged in the healthy upgrading of oils and the development and application of fat replacement technology based on bio-oil refining technology, and has launched a series of edible oil products.

HERO Software

Series B in 2024
HERO Software provides cloud-based solutions aimed at enhancing office efficiency through digitization. Their platform enables companies to streamline their project management processes from initial contact through implementation and invoicing. Key features of the HERO app include customer and project management, appointment scheduling, construction site documentation, and task management, all designed to support field operations and client visits. The software helps businesses manage the entire order-processing cycle, monitor project progress, and handle planning and invoicing, ultimately improving communication and operational efficiency.

Canoe

Series C in 2024
Canoe Software Inc. provides a sophisticated software solution focused on financial document and data management. Founded in 2013 and based in New York, the company specializes in automating the extraction and organization of investment documents using artificial intelligence and machine learning technologies. This enables users to efficiently convert unstructured data from various formats, such as PDFs, into actionable insights, thereby improving operational efficiency. Canoe's platform supports a wide range of clients, including single and multi-family offices, endowments, foundations, pensions, investment consultants, and financial institutions, facilitating better management of post-investment operations, monitoring, and reporting. By streamlining the data management process, Canoe helps minimize manual data entry and enhances the accuracy of financial reporting and analysis.

Odaseva

Series C in 2024
Odaseva is a company specializing in data management solutions for large enterprises utilizing Salesforce. It offers a comprehensive cloud-based platform that focuses on data protection, privacy, and governance. The Odaseva Enterprise Data Security Platform is designed to ensure the confidentiality, integrity, and availability of critical business information by providing integrated security products and services. Key features of the platform include backup and recovery, archiving, monitoring of governor limits, and compliance support for regulations such as GDPR. By enabling businesses to take full control of their data, Odaseva helps eliminate risks and facilitates confident digital transformation.

Fibe

Secondary Market in 2024
Fibe is a prominent consumer lending application in India, catering to the financial needs of young, aspirational, and tech-savvy individuals. The company has developed an online financial platform that specializes in providing ultra short-term loans and salary advances. Its services include small bridge loans that assist customers until their next salary credit, as well as small loans designed to help users navigate financial challenges at the end of the month. By offering accessible and timely financial solutions, Fibe aims to support users during critical times, making it a valuable resource for managing immediate credit needs.

Fibe

Series E in 2024
Fibe is a prominent consumer lending application in India, catering to the financial needs of young, aspirational, and tech-savvy individuals. The company has developed an online financial platform that specializes in providing ultra short-term loans and salary advances. Its services include small bridge loans that assist customers until their next salary credit, as well as small loans designed to help users navigate financial challenges at the end of the month. By offering accessible and timely financial solutions, Fibe aims to support users during critical times, making it a valuable resource for managing immediate credit needs.

Arnatar Therapeutics

Series A in 2024
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.

Pelago

Series C in 2024
Pelago, formerly known as Quit Genius, is a leading virtual clinic focused on substance use management, specializing in support for individuals struggling with addictions to tobacco, alcohol, and opioids. The company provides a comprehensive approach to substance use support, offering education, management skills, and opportunities for positive change. Pelago's platform utilizes cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) to deliver accessible and effective support tailored to individual needs. This service is designed to integrate seamlessly with health plans, pharmacy benefit managers, and wellness platforms, enabling employers to offer on-demand, personalized assistance to employees seeking healthier lifestyles. To date, Pelago has successfully assisted over 750,000 members in managing their substance use and improving their overall well-being. The platform features engaging resources such as animated videos, interactive exercises, and audio sessions, empowering users to confront their addictions in a personalized manner with the guidance of a coach.

Engrail Therapeutics

Series B in 2024
Engrail Therapeutics, Inc. is dedicated to developing and commercializing neuro drugs aimed at treating diseases of the nervous system. Founded in 2019 and based in San Diego, California, the company focuses on creating transformative medicines to alleviate the significant burden of such conditions. One of its key products is ENX-101, a preclinical compound designed to modulate a receptor for GABA, a critical neurotransmitter in the brain. Engrail Therapeutics combines biological insights with clinically meaningful solutions to advance its portfolio of therapies, utilizing a flexible transaction model to efficiently progress its drug candidates from development to commercialization.

HiLabs

Series B in 2024
HiLabs is a developer of a healthcare data mining platform that aims to enhance data-driven decision-making within healthcare organizations. By leveraging artificial intelligence, HiLabs empowers employees to explore their data intuitively, uncover novel insights, and interact with data visualizations. The platform allows users to customize dashboards and generate new attributes, thus enhancing their ability to understand and utilize client health data effectively. HiLabs recognizes that healthcare providers possess vital domain knowledge but often lack the necessary tools to extract meaningful insights from their data. Through its innovative solutions, HiLabs bridges this gap, enabling healthcare organizations to harness their data more efficiently and improve overall decision-making processes.

Shadowfax

Series E in 2024
Shadowfax is an on-demand logistics network that specializes in providing tech-enabled delivery solutions across various sectors, including e-commerce, food, pharmacy, and consumer goods. By leveraging its unique app, the company offers a reliable last-mile delivery service, allowing businesses to concentrate on their core operations while outsourcing their delivery needs. Shadowfax aims to enhance the customer experience through efficient, fast, and dependable delivery options. Its platform serves both online and offline retailers, catering to the diverse logistics demands of merchants and ensuring timely service. The company envisions establishing itself as a trustworthy and desirable delivery platform, emphasizing the use of advanced technology to streamline logistics and improve customer satisfaction.

EurekaBio

Series B in 2024
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.

Newmo

Seed Round in 2024
Newmo is a technology company that specializes in sustainable local public transportation. It develops a ride-sharing service platform, enabling drivers to work flexibly using their free time, and providing passengers with a safe, secure, and comfortable user experience.

OpenLogi

Series D in 2024
OpenLogi Inc. is a Tokyo-based company that specializes in providing an outsourced logistics platform tailored for small and medium-sized enterprises (SMEs) and freelancers. Founded in December 2013 by Hidetsugu Ito, the company aims to address logistics challenges faced by small e-commerce businesses. OpenLogi's platform offers a comprehensive dashboard that includes features for warehouse inspection, storage management, shipping, and handling of returns. By leveraging unused warehouse capacity and optimizing logistics operations through advanced technology, OpenLogi enables clients to streamline their logistics processes and reduce costs. The company's focus on affordability and efficiency positions it as a vital partner for SMEs seeking effective logistics solutions.

La Fourche

Series B in 2024
La Fourche is an online retail platform dedicated to making healthy consumption accessible to a broader audience by offering a wide range of organic products at affordable prices. The company operates on a subscription model, providing customers with access to thousands of organic food and grocery items at discounts of up to 50%. This approach allows families to significantly reduce their spending on healthy products, potentially saving up to 1000€. La Fourche emphasizes the importance of socially responsible and environmentally friendly practices in its offerings, ensuring that consumers can choose from a diverse selection of healthy and sustainable products.

Xbit

Venture Round in 2024
Xbit is a developer of a shift management system that provides an innovative chatbot service for shop owners. This platform enables businesses to efficiently gather employee availability and create effective shift schedules. By addressing customer issues and needs, Xbit implements tailored solutions that enhance operational efficiency. The company focuses on optimizing business processes, allowing clients to reduce costs while maintaining high service quality through proper personnel allocation.

makeO

Series D in 2024
makeO is a developer of an innovative oral and skin care platform that allows individuals to attain their desired smile and complexion. The company offers a range of at-home solutions, including invisible aligners for teeth straightening, products for teeth whitening, and skin rejuvenation treatments such as laser hair removal and scientifically formulated skincare products. By providing these accessible options, makeO empowers customers to manage their beauty journeys conveniently and effectively.

Everheal

Venture Round in 2024
Everheal is a health-tech startup focused on providing comprehensive support for women during the pre-conception, pregnancy, and post-partum periods. The company operates a maternity care center and an integrated platform designed to enhance clinical outcomes for mothers. Everheal offers gynecologists an all-in-one solution that includes patient support features, technology-assisted service packages, an e-store, and monitoring devices. Key services encompass nutrition tracking, video consultations, and automated vital sign monitoring for patients dealing with gestational diabetes or hypertension. By consolidating multiple healthcare services into a single platform, Everheal aims to improve the overall maternal healthcare experience.

Eon

Seed Round in 2024
Eon is a technology company specializing in enterprise backup and recovery solutions. It offers a cloud-based platform that automatically maps and classifies data, ensuring only critical information is stored. The platform enhances operational efficiency by managing and securing backups, identifying and mitigating data storage risks, and prioritizing essential data for storage.

Micoworks

Series B in 2023
Micoworks is a planning and development platform designed to enhance communication and marketing strategies for businesses. It specializes in personalizing the customer experience by offering tools that facilitate optimal communication and automate various processes. The platform allows clients to categorize their business based on customer information and streamlines customer interviews, conversations, and reservation flows. By leveraging these features, Micoworks enables organizations to plan and develop their operations more efficiently.

PlasmaGen Biosciences

Venture Round in 2023
PlasmaGen Biosciences Pvt. Ltd., established in 2010 and based in Bengaluru, India, is a biopharmaceutical company specializing in plasma protein therapies. The company manufactures a range of products including PlasmaGlob and AlbuMax, brands of Normal Human Immunoglobulin for Intravenous use, PlasmaRho-D I.V. for Rh immunization suppression, PlasmaRAB for rabies infection prophylaxis, PlasmaHep for hepatitis B exposure, VerBumin for conditions like hypovolemic shock and burns, and Gammafact-VIII. These products cater to various medical fields such as hematology, oncology, immunology, pediatrics, rheumatology, dermatology, and neurology. The company serves clinicians, medical practitioners, corporate hospitals, and government institutions.

Exponent Energy

Series B in 2023
Exponent Energy is a start-up dedicated to enhancing electric vehicle (EV) charging through innovative fast charging technology. The company specializes in battery-swapping infrastructure, aiming to provide a more efficient and cost-effective charging solution for EV users. It manufactures an integrated energy stack designed to minimize impedance build-up, which facilitates a smooth energy flow. This system includes a cohesive battery management system, battery pack, and charger that work in unison to streamline the charging process. By focusing on these advancements, Exponent Energy seeks to simplify and accelerate the energy replenishment for electric vehicles, catering to the growing demand for sustainable transportation solutions.

Shinobi Therapeutics

Series A in 2023
Shinobi Therapeutics is a biotechnology company dedicated to developing innovative cell therapies that utilize hypoimmune CD8αβ induced pluripotent stem cells (iPS-T cells) to enhance cancer treatment and address other diseases. The company's advanced immune evasion technology aims to improve the effectiveness and accessibility of these therapies, ultimately reducing costs and enhancing patient outcomes. By focusing on durable responses and the potential for redosing, Shinobi Therapeutics strives to provide the healthcare industry with comprehensive immune therapies that can address a range of diseases, including cancer and genetic disorders.

Eleos Health

Series B in 2023
Eleos Health is a technology company that specializes in artificial intelligence-driven solutions for the behavioral health sector. It has developed a voice technology platform designed to enhance clinicians' decision-making by providing real-time insights during mental health sessions. This AI-powered system operates in the background, analyzing voice interactions and other data parameters to generate valuable information about patients. By leveraging this technology, Eleos Health aims to facilitate personalized care, ensuring that mental health professionals can deliver timely and cost-effective support tailored to individual needs.

Sonosemi Medical

Series B in 2023
Sonosemi Medical is a provider of medical devices that specializes in the development of pan-vascular active interventional products, diagnosis, and treatment solutions.

La Fourche

Series B in 2023
La Fourche is an online retail platform dedicated to making healthy consumption accessible to a broader audience by offering a wide range of organic products at affordable prices. The company operates on a subscription model, providing customers with access to thousands of organic food and grocery items at discounts of up to 50%. This approach allows families to significantly reduce their spending on healthy products, potentially saving up to 1000€. La Fourche emphasizes the importance of socially responsible and environmentally friendly practices in its offerings, ensuring that consumers can choose from a diverse selection of healthy and sustainable products.

AlphaGen Therapeutics

Seed Round in 2023
AlphaGen Therapeutics is a biotechnology company specializing in the development and provision of radiopharmaceutical products for cancer treatments. Its core focus is on innovative radioligand therapies, utilizing alpha nuclide radiopharmaceuticals, with additional drugs in early clinical trials. The company aims to deliver innovative radiotherapy solutions to patients, leveraging its cutting-edge technology.

Pixocial

Series A in 2023
Pixocial is a software company specializing in AI-powered photo and video editing solutions. It caters to a wide range of clients, from individual creators and small businesses to large enterprises, offering tools for portrait editing, campaign-driven effects, AR-powered content, and web and desktop toolkits for social media content generation. The company's platform also fosters a creative community, providing global users with advanced editing capabilities and resources to produce and manage digital images and videos.

ScyllaDB

Series C in 2023
ScyllaDB is a company specializing in the development of high-performance, scalable column store database software, particularly suited for data-intensive applications. It offers both open-source and enterprise versions of its product, which can be deployed in various environments, alongside ScyllaDB Cloud, a fully-managed Database as a Service available on major cloud platforms like AWS and Google Cloud. The software is designed to support wide-column NoSQL workloads and is fully compatible with popular systems such as Apache Cassandra and Amazon DynamoDB. Founded as Cloudius Systems, ScyllaDB is based in Herzliya, Israel, and aims to deliver exceptional performance and low latency while reducing costs, enabling organizations to leverage modern multi-core servers effectively as their data needs evolve.

Doceree

Series B in 2023
Doceree Inc is a healthcare marketing technology company that operates a programmatic physician engagement and advertising platform. Founded in 2019 and based in Parsippany, New Jersey, with an additional office in New Delhi, India, Doceree connects pharmaceutical and healthcare brands with healthcare professionals (HCPs) through targeted advertising and data-driven solutions. The platform leverages artificial intelligence, data segmentation, and analytics to accurately identify and engage HCPs across various digital platforms, including physician networking sites and medical journals. By providing access to physician-only platforms, Doceree enables media agencies, pharmaceutical companies, medical device manufacturers, consumer healthcare brands, and hospitals to deliver compliant and effective messaging at scale.

Cataya Bio

Series B in 2023
Cataya Bio (Shanghai) Co., Ltd. is a biotechnology company focused on developing synthetic biological products for various industries. Utilizing an advanced engineering biology platform, Cataya Bio engineers microbes and implements clean fermentation processes to produce high-purity products efficiently and sustainably. The company aims to facilitate the transition from petroleum-based materials to natural and sustainable raw materials, addressing critical global challenges such as environmental preservation, carbon emissions, and climate change. Through its innovative approach, Cataya Bio provides clients with effective solutions for sourcing raw materials that align with contemporary sustainability goals.

New Vision Medical

Series A in 2023
New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.

Tenpoint Therapeutics

Series A in 2023
Tenpoint Therapeutics is a biotechnology company dedicated to developing engineered cell-based therapies aimed at restoring vision for individuals affected by degenerative ocular diseases. The company leverages an innovative platform that includes in vivo reprogramming techniques, allowing for targeted delivery of therapeutic systems directly to the eye. This approach eliminates the need for systemic administration, which can improve treatment efficacy and patient outcomes. By focusing on vision restoration, Tenpoint Therapeutics strives to significantly enhance the quality of life for patients suffering from various eye conditions.

Raft

Series B in 2023
Raft is a smart logistics platform focused on automating the freight process to enhance control and visibility in logistics operations. It leverages artificial intelligence to analyze and act on incoming shipment data, significantly reducing the time operators spend on information retrieval and manual data entry. By automating various tasks, including accounts payable invoices, customs documentation, and shipping workflows, Raft enables freight forwarders and customs brokers to minimize manual work, thus improving accuracy and compliance. The platform's real-time processing capabilities further allow operators to manage shipments more efficiently, ensuring timely and reliable service for their customers.

Chian Technology

Venture Round in 2023
Chian Technology is a developer of a network security system. The company's product line includes standardized zero-trust products as well as customized zero-trust solutions based on the personalized circumstances of various customers, allowing users to obtain multi-faceted network security protection. Their products are used in fields such as the Internet, finance, energy, technology, high-end manufacturing, new retail, and others.

K36 Therapeutics

Series B in 2023
K36 Therapeutics is a biotechnology company focused on developing small molecule therapeutics for cancer treatment. The company specializes in translating epigenetic modulation of oncogenic pathways into effective therapies. By leveraging advanced technology, K36 Therapeutics creates orally bioavailable small molecules and selective inhibitors, aiming to enhance the treatment options available to healthcare professionals and improve outcomes for cancer patients.

BTP Automation

Grant in 2023
BTP Automation specializes in the collection and analysis of corporate travel hotel data from various sources to create automated cost savings for businesses. The company has developed a hotel sourcing management platform that integrates business intelligence and analytics into corporate travel practices. This platform aids travel buyers by providing real-time insights on key performance indicators in hotel program management, allowing for the automation of the entire program and maximizing its value. Additionally, BTP Automation's technology enables companies to offer insights into hotel attachment rates, supporting clients in the implementation of strategic hotel management initiatives.

Adcentrx Therapeutics

Series A in 2023
Adcentrx Therapeutics is a biotechnology company dedicated to advancing protein conjugate therapeutics aimed at treating cancer and other life-threatening diseases. The company focuses on developing next-generation targeted therapies that leverage the precision of biologics combined with the efficacy of small molecule payloads. Through its innovative approach, Adcentrx aims to enhance treatment options for patients, providing them with more effective and targeted therapeutic solutions.

SAFE Security

Series B in 2023
SAFE Security, also known as Lucideus Tech Private Limited, is a cyber risk management company headquartered in New Delhi, India. Founded in 2012, it specializes in providing comprehensive information technology risk assessment and digital security services to organizations globally. The company develops a cyber risk quantification and management platform that enables businesses to continuously monitor and respond to cyber threats in real time. SAFE Security's offerings include IT security maturity assessments, governance policy formation, application security, IT infrastructure security, and emergency response services. By establishing a common risk taxonomy, the platform facilitates better communication among stakeholders and shifts the focus of security discussions from tactical projects to strategic value, ultimately helping organizations mitigate cyber risks through prioritized actionable insights.

Aden Financial Group

Series A in 2023
Aden Financial Group operates a cross-border over-the-counter (OTC) assets e-trading platform focused on facilitating trades denominated in Chinese renminbi. The platform provides a comprehensive suite of services that includes alternative data display, price discovery, automatic trade-matching, and click-to-trade functionalities. This enables international investors, including ultra-high-net-worth individuals, family offices, and funds, to access and invest in the Greater Chinese markets and assets efficiently.

Lanzhou Technology

Seed Round in 2023
Lanzhou cognitive intelligence platform is an industrial service cloud platform with NLP as the core, providing a series of services such as a graph, machine translation, assisted writing, sentiment analysis, intelligent retrieval, intelligent customer service, document analysis, etc. Enter search, generation, translation, dialogue, and other business scenarios. They provide solutions for financial, marketing, cultural, and creative industries, focusing on the core scenarios in the industry to provide solutions to help enterprises upgrade intelligently.

TandemAI

Series A in 2023
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.

Canoe

Series B in 2023
Canoe Software Inc. provides a sophisticated software solution focused on financial document and data management. Founded in 2013 and based in New York, the company specializes in automating the extraction and organization of investment documents using artificial intelligence and machine learning technologies. This enables users to efficiently convert unstructured data from various formats, such as PDFs, into actionable insights, thereby improving operational efficiency. Canoe's platform supports a wide range of clients, including single and multi-family offices, endowments, foundations, pensions, investment consultants, and financial institutions, facilitating better management of post-investment operations, monitoring, and reporting. By streamlining the data management process, Canoe helps minimize manual data entry and enhances the accuracy of financial reporting and analysis.

NOCD

Series B in 2023
NOCD Inc. is a Chicago-based company founded in 2014 that specializes in developing a mobile application aimed at assisting individuals with obsessive-compulsive disorder (OCD). The platform connects users to licensed therapists who specialize in OCD through face-to-face video therapy sessions. Utilizing cognitive behavioral therapy techniques, the application guides users in self-treatment and monitoring of their symptoms, offering tools for exposure and response prevention exercises. In addition to therapy sessions, NOCD provides 24/7 support via self-help resources and peer communities, facilitating ongoing care and enabling patients to manage their condition effectively. The company focuses on improving treatment outcomes for OCD through its innovative online platform.

Enko Chem

Series C in 2023
Enko Chem, Inc., established in 2017 and based in Woburn, Massachusetts, specializes in the discovery and development of small-molecule and novel products designed to protect crops from pests and diseases. The company's proprietary technology platform enables it to swiftly identify safe and cost-effective solutions, contributing to sustainable food production.

Enzene Biosciences

Venture Round in 2023
Enzene Biosciences is a biotechnology company focused on providing affordable medicines through the development of biosimilars. The company leverages advanced technologies and sophisticated analytics within its state-of-the-art manufacturing facilities to ensure cost-effective production. Enzene specializes in cloning, process development, and novel formulation development, enabling clients in the microbial manufacturing sector to adopt innovative solutions that improve healthcare outcomes. Additionally, the company aims to expand its reach and impact by forming strategic global alliances, while fostering a distinctive work culture that positions it as a desirable employer in the biotech industry.

Cloudian

Venture Round in 2023
Cloudian is a company that specializes in file and object storage, particularly focusing on S3 object storage within data centers. It offers a hybrid cloud data management platform that allows customers to optimize data access, meet data sovereignty requirements, and reduce costs by consolidating information into a single, cloud-like environment. Cloudian's platform provides scalable and secure object storage for hybrid cloud deployments, enabling organizations to effectively manage and protect their data both on-premises and in the cloud. With its emphasis on data durability and user-friendly management tools, Cloudian aims to transform enterprise data into actionable insights while ensuring compatibility with the industry-standard S3 API.

Coho AI

Seed Round in 2023
Coho AI is a company that provides a product-led revenue platform designed to enhance the effectiveness of growth, customer success, and sales teams. Founded in 2021 and based in New York, the company leverages artificial intelligence to integrate with existing B2B SaaS tools, offering a comprehensive analysis of user interactions with products. This platform empowers businesses to make informed decisions based on user behavior data, facilitating increased upsells, expansions, and self-service conversions. By focusing on the right revenue opportunities, Coho AI aims to help teams improve conversion rates and deliver greater value to users.

MEIHUAMEDICAL

Series B in 2022
MEIHUAMEDICAL develops, produces and sells microbial medical instruments & diagnostic reagents.

Alternative Bio

Seed Round in 2022
Alternative Bio is a biotechnology company focused on developing novel therapeutics targeting a previously untapped class of post-translational modifying enzymes.

RedPine Medical

Series C in 2022
RedPine Medical, founded in 2015 and headquartered in Guangzhou, China, specializes in the manufacture of single-use medical endoscopes. The company focuses on providing advanced minimally invasive surgical devices for various applications, including urology, gynecology, ear, nose, and throat (ENT), pneumology, gastroenterology, and general surgeries. By emphasizing innovative solutions, RedPine aims to enhance detection, diagnosis, and treatment in medical settings, positioning itself as a global leader in the field of integrated minimally invasive surgical solutions.

ABK Biomedical

Series C in 2022
ABK Biomedical Inc. is a Halifax-based company founded in 2012 that specializes in developing embolotherapeutic products aimed at treating conditions such as uterine fibroids, hypervascular tumors, and arteriovenous malformations. The company focuses on enhancing treatment options through innovative biomaterials, particularly by transforming the interventional radiology procedure known as embolization. ABK Biomedical has developed a novel radiopaque microsphere product that serves as a bland embolic agent, emitting beta radiation to improve targeting of tumor vascularity and tissue. This innovation aims to standardize, optimize, and personalize minimally invasive therapies for better patient outcomes.

Ruiyun Cold Chain

Seed Round in 2022
Ruiyun Cold Chain is a logistics service platform in China that specializes in cold chain transportation. Utilizing innovative domestic technology, the company offers comprehensive, digital, end-to-end cold chain integration services. Its proprietary platform, which includes Lengyunbao, a unique carrier-type online trading system, facilitates a seamless online experience for transactions, delivery, settlement, and tax collection. By fostering interaction and collaboration within a social cold chain network, Ruiyun Cold Chain effectively links industry resources with customer demand, helping businesses optimize operational efficiency and achieve significant reductions in logistics costs, typically between 10% and 15%.

Red Points

Venture Round in 2022
Red Points is a technology company based in Barcelona, Spain, that specializes in online brand protection. Founded in 2011, the company offers a software-as-a-service platform designed to combat online counterfeiting, digital piracy, and distribution fraud. Utilizing advanced machine learning and computer vision techniques, Red Points' software effectively detects and removes counterfeit goods and pirated content from the internet. The platform operates across more than one hundred online marketplaces and social networks, addressing hundreds of thousands of incidents each month. With a client base that includes over five hundred brands worldwide, such as Bang & Olufsen, MVMT, and DOPE, Red Points provides essential solutions for brands and content owners seeking to safeguard their intellectual property rights in the digital landscape.

Cataya Bio

Series A in 2022
Cataya Bio (Shanghai) Co., Ltd. is a biotechnology company focused on developing synthetic biological products for various industries. Utilizing an advanced engineering biology platform, Cataya Bio engineers microbes and implements clean fermentation processes to produce high-purity products efficiently and sustainably. The company aims to facilitate the transition from petroleum-based materials to natural and sustainable raw materials, addressing critical global challenges such as environmental preservation, carbon emissions, and climate change. Through its innovative approach, Cataya Bio provides clients with effective solutions for sourcing raw materials that align with contemporary sustainability goals.

Elucidata

Series A in 2022
Elucidata Corporation, established in 2015 and based in New Delhi, India, specializes in accelerating drug discovery by translating phenotypic screenings into therapeutic strategies. The company's core offering is Polly, a proprietary SaaS platform that transforms drug discovery through curated biomedical molecular data. Polly hosts over 230,000 multi-omic datasets, with around 50,000 new datasets added monthly, and offers exclusive access to curated data ready for machine learning workflows. This platform enables 10x faster identification of therapeutic assets and has facilitated the detection of multiple validated drug targets across immunology, oncology, and metabolomic disorders. Polly supports discovery programs at prominent biopharma companies such as Pfizer, Agios Pharmaceuticals, Genentech, and Yale, with over 35 research partners from premier institutions.

Bhanzu

Series A in 2022
Bhanzu is an innovative math-learning platform focused on fostering interest in mathematics and STEM careers among students of all ages. Its meticulously designed curriculum provides a customized learning experience tailored to individual needs, helping learners enhance their cognitive abilities and develop a strong foundational understanding of math. The platform features a variety of educational resources, including videos aimed at alleviating math anxiety for young learners in grades 1 to 3. By emphasizing experiential learning, Bhanzu enables students to improve their mathematical skills and apply concepts effectively in real-world scenarios.

Qixiangyun

Seed Round in 2022
Qixiangyun is a pioneering enterprise in China that specializes in developing an open platform for financial and taxation standard components. The company focuses on empowering independent software vendors (ISVs) by providing high-quality, standardized financial and taxation technology services tailored for terminal enterprises. Its platform features an intelligent financial and tax report accounting engine at its core, offering APIs and configurable functional modules that can seamlessly integrate with various enterprise software systems. This integration facilitates efficient digital transformation across business, finance, and taxation sectors. Additionally, Qixiangyun aims to streamline the national tax declaration process, enabling multi-enterprise and cross-regional one-click tax declaration and deduction, significantly enhancing the operational capabilities of enterprises in the digital age.

InsightFinder

Series A in 2022
InsightFinder Inc. is a technology company that specializes in machine learning solutions for IT operational data. Founded in 2015 and based in Brooklyn, New York, the company utilizes patented unsupervised machine learning algorithms to address complex challenges in enterprise AI and IT management. InsightFinder offers a range of products, including a metric intelligence engine for automatic anomaly detection, a log intelligence engine for real-time keyword extraction, and an alert intelligence engine that reduces alert fatigue by filtering duplicate notifications. Additionally, the APM intelligence engine identifies issues in both proprietary and third-party applications. Through its AI Observability and IT Observability solutions, InsightFinder empowers large organizations to automatically detect, diagnose, and resolve IT incidents, thereby enhancing operational efficiency and minimizing disruptions.

StashAway

Series D in 2022
StashAway Malaysia Sdn Bhd is a licensed investment platform in Malaysia that specializes in wealth management and portfolio management for both retail and accredited investors. The company is dedicated to providing accessible investment solutions, emphasizing low fees and personalized financial planning. StashAway's platform caters to a diverse audience by offering tools and resources that facilitate informed investment decisions. Its innovative investment strategy, ERAA® (Economic Regime-based Asset Allocation), aims to maximize long-term returns while managing individual risk exposure in response to changing economic conditions. Through its user-friendly mobile app, StashAway simplifies the investment process, making wealth management more approachable for a broad range of investors.

Jade Bird Display

Series A in 2022
Jade Bird Display (Shanghai) Limited is a manufacturer based in Shanghai, China, specializing in the development and production of micro-LED display chips and panels. Founded in 2015, the company focuses on research and development to create the smallest, brightest, and most efficient micro-display solutions. Its products are designed for various applications, including augmented reality (AR), virtual reality (VR), head-up displays (HUD), projectors, weapon sights, 3D printing, and microscopes. By providing ultra-compact micro-display panels, Jade Bird Display enables original equipment manufacturers to enhance user experience in AR and VR hardware, offering improved comfort, outdoor readability, and extended operating times between charges. The company also maintains an office in Hong Kong to support its operations.

Lingtan Intelligent Technology

Seed Round in 2022
Lingtan Intelligent Technology specializes in the development of innovative and sustainable distributed energy storage products and services. The company is dedicated to researching and developing hardware and software for energy storage systems, as well as virtual power plant trading platforms. Lingtan aims to provide energy storage-based solutions tailored for various industrial and commercial markets, including factories, commercial buildings, charging stations, and data centers. Through its focus on advanced technology, the company seeks to enhance energy efficiency and sustainability across multiple sectors.

Enko Chem

Series C in 2022
Enko Chem, Inc., established in 2017 and based in Woburn, Massachusetts, specializes in the discovery and development of small-molecule and novel products designed to protect crops from pests and diseases. The company's proprietary technology platform enables it to swiftly identify safe and cost-effective solutions, contributing to sustainable food production.

Asobica

Venture Round in 2022
Asobica, Inc. is a Japanese company based in Shinagawa that focuses on the planning, development, and management of Internet-based businesses. The company aims to revitalize traditional industries through innovative technology and community engagement. Its flagship product, fever, serves as a platform for issuing community coins, fostering active participation within user communities. Asobica's software suite includes tools for customer relationship management, customer analysis, and community coin issuance, all designed to enhance user engagement and loyalty. By leveraging these technologies, Asobica seeks to support sustainable corporate growth and improve customer retention for its clients.

ProcessOn

Series A in 2022
ProcessOn is a developer of online diagramming and collaboration tools that facilitate the creation of flowcharts, mind maps, BPMN, UML diagrams, and more. The platform serves as a social network for business processes, enabling users to collaborate in real-time on diagram creation and sharing. This functionality allows teams to visualize complex ideas and processes collectively, thereby enhancing understanding and retention of abstract concepts. In addition to its primary mapping tool, ProcessOn offers Little Drawing Table, a visual collaboration whiteboard software that supports brainstorming and client discussions on a single digital canvas. This dual approach not only provides mapping capabilities but also fosters a community where users can share knowledge and access a diverse database of diagrams.

Kaiko

Series B in 2022
Kaiko is a provider of digital asset market data services, offering global connectivity to over 100 centralized and decentralized cryptocurrency exchanges. Its mission is to bridge traditional finance with crypto by delivering actionable financial data through four business units: Market Data, Quantitative Analytics, Indices, and Research. Kaiko empowers various use cases across the investment lifecycle for both investors and enterprises.

Gloat

Series D in 2022
Gloat is an innovative Internal Talent Marketplace that empowers organizations to unlock and utilize the hidden potential of their workforce. Through its AI-driven platform, Gloat matches employees' skills and aspirations with suitable internal career opportunities, fostering personalized career development in real time while maintaining user anonymity. This approach not only supports individual career growth but also enhances organizational agility and visibility. Gloat is utilized by prominent companies around the globe, with deployments in over 120 countries, including major brands such as Unilever, PepsiCo, and HSBC. By providing valuable insights and data-driven recommendations, Gloat enables individuals to make informed career decisions and helps managers identify the right candidates for various roles within their organizations.

Changjin Biotechnology

Series A in 2022
Developer of edible microbial synthetic protein food intended to provide new form of protein sources. The company focuses on the research, development and industrialization of new microbial proteins and biosynthetic proteins, enabling clients with safe, nutritious and delicious microbial substitute protein artificial food, while lowering carbon emissions.

Spry

Series A in 2022
Spry is a digital health platform that enables movement health professionals to collect and analyze patient data in real time. By leveraging machine learning and artificial intelligence, the platform provides personalized protocols based on evidence-based practices and standards of care. This allows practitioners and owners of physical therapy centers to effectively manage both clinical and administrative functions, enhancing the quality of patient care and operational efficiency.

EurekaBio

Series B in 2022
EurekaBio specializes in developing solutions for cancer immunotherapy, particularly in the realm of cell therapy. The company offers automated manufacturing equipment for cell therapies and a platform for vector production. By focusing on automation in medical equipment related to gene and cell therapy, EurekaBio aims to enhance the accuracy and efficiency of cancer treatments, ultimately benefiting patients in need of innovative therapeutic options.

Immuneel Therapeutics

Series A in 2022
Immuneel Therapeutics specializes in developing innovative cell and gene therapies for cancer treatment. The company focuses on CAR-T cell therapies, which are created by extracting blood cells from patients and genetically engineering healthy immune cells to specifically target malignant cells. This approach allows cancer patients to benefit from advanced cell-based immunotherapies that have the potential to transform their treatment outcomes.

Proximie

Series C in 2022
Proximie Inc., headquartered in Bedford, Massachusetts, operates a health technology platform that facilitates remote, real-time collaboration among surgeons worldwide. The company's core service enables surgeons to virtually attend operations via augmented reality, artificial intelligence, and machine learning technologies. This allows them to visually guide complex surgeries, demonstrate techniques, and provide expertise remotely, thereby democratizing access to advanced surgical knowledge globally. Founded by Nadine Hachach-Haram in 2016, Proximie aims to enhance surgical outcomes and improve patient care through innovative telehealth solutions.

MoEngage

Series E in 2022
MoEngage, Inc. is a technology company that provides a cloud-based user analytics and engagement platform aimed at enhancing customer retention and lifetime value for consumer businesses. Founded in 2014 and headquartered in San Francisco, California, the company serves various industries, including e-commerce, telecommunications, travel and hospitality, and banking and finance. MoEngage's platform enables businesses to deliver personalized interactions through multiple channels, such as push notifications, in-app messaging, web push, and SMS, all managed from a single dashboard. With a focus on machine learning, the platform optimizes customer engagement by analyzing user behavior and delivering tailored recommendations. MoEngage also has offices in several international locations, including Bengaluru, Singapore, London, Jakarta, Bangkok, Ho Chi Minh City, and Berlin.

Quantstamp

Series A in 2022
Quantstamp Inc., established in 2017 and headquartered in Dover, Delaware, specializes in blockchain security. The company offers comprehensive security services, including thorough audits, protocol testing, and vulnerability assessments, ensuring the reliability and integrity of blockchain ecosystems. Its software is designed to detect and respond to suspicious activities, conducting smart contract, off-chain, networking, and front-end audits to enhance the security of decentralized applications.

Wint Wealth

Series A in 2022
Wint Wealth is a financial services company that specializes in providing high net-worth individuals and retail investors with asset-backed fixed income products designed to yield higher returns than traditional fixed deposits. By leveraging a digital investment platform, Wint Wealth democratizes access to previously exclusive investment opportunities, allowing clients to invest in high-yield asset-backed securitized debt instruments with a minimum investment as low as Rs. 10,000. This innovative approach enables investors to engage with safer investment options that typically require substantial capital, thus bridging the gap between low-risk, low-return investments and higher-yield alternatives.

BlissClub

Series A in 2022
BlissClub is a pioneering women's activewear brand focused on creating comfortable and functional apparel specifically for Indian women. The company designs products such as leggings and sports bras, addressing prevalent challenges in women's activewear related to fabric, fit, and function. By prioritizing a community-driven approach, BlissClub aims to empower women to find suitable sportswear that meets their needs, while also providing the convenience of home delivery.

Invetx

Series B in 2022
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.

Toothsi

Series C in 2022
Toothsi is a dental company that offers clear aligners, an alternative to traditional braces, to gradually shift teeth into proper alignment. Toothsi's aligners are removable, invisible, and more comfortable than metal braces. Toothsi also provides oral hygiene products, teeth whitening solutions, and aligner accessories for complete oral care.

Reveal

Series A in 2022
Reveal, formerly known as Sharework, is the free platform for Partnership, Marketing, and Sales teams to generate revenue through their ecosystem. Reveal allows you to connect with companies from your ecosystem, securely compare your CRM data, and multiply up to 3X your win rate thanks to your ecosystem’s insights.

Worktile Technology

Series C in 2022
Worktile Technology, established in 2013, is a Chinese software company headquartered in Beijing, with offices in Shanghai, Shenzhen, and Xi'an. It specializes in a web and mobile-based project management tool, designed to enhance team collaboration and productivity among developers and professionals. The platform facilitates task management, communication, and document sharing, aiming to streamline work processes and improve overall enterprise efficiency.

Noogata

Series A in 2022
Noogata is an AI-powered eCommerce platform designed to provide insights and strategic guidance for consumer packaged goods (CPG) companies, digital brands, and agencies, facilitating the growth of their eCommerce operations. The platform simplifies the discovery of insights for eCommerce professionals by offering competitive intelligence, consumer search insights, and AI tools that enhance digital shelf performance. Noogata's solution enables users to visualize, measure, and act on data effortlessly, monitoring thousands of products and categories to deliver actionable insights. This approach empowers brands to optimize their sales, advertising, and pricing strategies, helping them to stay competitive and increase revenue, particularly on platforms like Amazon. The company is backed by prominent venture capital firms, underscoring its innovative approach to leveraging AI in the eCommerce space.

Doceree

Series A in 2022
Doceree Inc is a healthcare marketing technology company that operates a programmatic physician engagement and advertising platform. Founded in 2019 and based in Parsippany, New Jersey, with an additional office in New Delhi, India, Doceree connects pharmaceutical and healthcare brands with healthcare professionals (HCPs) through targeted advertising and data-driven solutions. The platform leverages artificial intelligence, data segmentation, and analytics to accurately identify and engage HCPs across various digital platforms, including physician networking sites and medical journals. By providing access to physician-only platforms, Doceree enables media agencies, pharmaceutical companies, medical device manufacturers, consumer healthcare brands, and hospitals to deliver compliant and effective messaging at scale.

Amenitiz

Series A in 2022
Amenitiz is a technology company that provides an all-in-one platform tailored for independent hoteliers. Its mission is to simplify and enhance the management of vacation properties, making it easier for hotel owners to attract guests, manage bookings, and create exceptional experiences. The platform centralizes essential tools, allowing users to build conversion-optimized websites and streamline operations. By focusing on accessibility and efficiency, Amenitiz aims to empower hoteliers worldwide, from urban centers to remote locations, ensuring they can achieve success and profitability in the competitive hospitality market.

Eleos Health

Series A in 2022
Eleos Health is a technology company that specializes in artificial intelligence-driven solutions for the behavioral health sector. It has developed a voice technology platform designed to enhance clinicians' decision-making by providing real-time insights during mental health sessions. This AI-powered system operates in the background, analyzing voice interactions and other data parameters to generate valuable information about patients. By leveraging this technology, Eleos Health aims to facilitate personalized care, ensuring that mental health professionals can deliver timely and cost-effective support tailored to individual needs.

eKincare

Series B in 2022
eKincare is an innovative health benefits platform that leverages AI to provide personalized healthcare solutions. Recognized as India’s first personal health assistant, the platform integrates technology and analytics to deliver preventive and predictive health services to organizations and their employees. eKincare offers a variety of online and offline healthcare services, including 24/7 access to medical consultations, health check-ups, medication purchasing and delivery, health coaching, mental wellness programs, and fitness services. By monitoring and gathering medical data from various healthcare providers, the platform enables users to track their health information and identify potential health risks, facilitating timely interventions to enhance overall well-being. Trusted by numerous Fortune 500 companies, eKincare aims to redefine the healthcare experience through a comprehensive and user-friendly approach.

Tibber

Series C in 2022
Tibber is a European digital electricity supplier established in 2016, operating in Norway, Sweden, and Germany. It specializes in providing smart, sustainable energy solutions to households, aiming to reduce residential electricity consumption by 20%. Tibber replaces traditional utilities with innovative technology, offering renewable energy at fair, transparent prices. Its user-friendly app enables real-time energy usage tracking and integration with various smart home devices, promoting energy-efficient habits. Additionally, Tibber sells energy-saving gadgets and has been licensed to balance the main power grid in Sweden using electric vehicles.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.